Related Experiment Video
Updated: Jul 18, 2026

07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
A comparison between multifocal and conventional VEP latency changes secondary to glaucomatous damage
Tomas M Grippo1, Donald C Hood, Fabio N Kanadani
1Department of Ophthalmology, The New York Eye and Ear Infirmary, New York, New York, USA.
Investigative Ophthalmology & Visual Science
|November 24, 2006
Summary
Conventional visual evoked potentials (cVEPs) and multifocal VEPs (mfVEPs) showed minimal latency delays in most glaucoma patients, contrary to prior research. These VEP tests may not effectively detect early ganglion cell damage in glaucoma.
Area of Science:
- Ophthalmology
- Neuroscience
- Visual electrophysiology
Background:
- Glaucoma is a progressive optic neuropathy characterized by retinal ganglion cell loss.
- Visual evoked potentials (VEPs) are electrophysiological tests used to assess the visual pathway's function.
- Prolonged VEP latency has been suggested as an indicator of ganglion cell damage and a tool for monitoring neuroprotection in glaucoma.
Purpose of the Study:
- To compare the latency of conventional visual evoked potentials (cVEPs) and multifocal VEPs (mfVEPs) in the same patients.
- To evaluate the utility of VEPs in detecting abnormal ganglion cells and monitoring neuroprotection in glaucoma.
Main Methods:
- Seventy-five glaucomatous eyes, 75 eyes with suspected glaucoma, and 41 control eyes were tested.
- Achromatic automated perimetry, mfVEP, and cVEP tests were performed on all participants.
- mfVEP used a scaled dartboard with 60 sectors of pattern-reversing checkerboards; cVEP used pattern-reversing checkerboards of 15 or 60 minutes width.
Main Results:
- A minority of glaucomatous eyes exhibited VEP latencies outside the normal range, with little difference between cVEP and mfVEP results.
- In the glaucoma group, 12.3% (15 min cVEP), 8% (60 min cVEP), and 17.3% (mfVEP) of eyes exceeded the normal latency range.
- VEP latency showed no clear relationship with the visual field's mean deviation in glaucomatous eyes.
Conclusions:
- Contrary to previous findings, prolonged VEP delays were observed in only a small proportion of glaucoma patients.
- Delayed VEPs may not be a reliable indicator of damaged, as opposed to lost, retinal ganglion cells.
- The results suggest that either damaged ganglion cells are rare in these patients or VEPs are insensitive to such damage.
Related Concept Videos
Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

